Acute kidney injury and risk of cardiovascular outcomes: A nationwide cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Acute kidney injury and risk of cardiovascular outcomes : A nationwide cohort study. / Schytz, Philip Andreas; Blanche, Paul; Nissen, Anders Bonde; Torp-Pedersen, Christian; Gislason, Gunnar H; Nelveg-Kristensen, Karl Emil; Hommel, Kristine; Carlson, Nicholas.

In: Nefrologia, Vol. 42, No. 3, 2022, p. 338-346.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Schytz, PA, Blanche, P, Nissen, AB, Torp-Pedersen, C, Gislason, GH, Nelveg-Kristensen, KE, Hommel, K & Carlson, N 2022, 'Acute kidney injury and risk of cardiovascular outcomes: A nationwide cohort study', Nefrologia, vol. 42, no. 3, pp. 338-346. https://doi.org/10.1016/j.nefro.2021.06.007

APA

Schytz, P. A., Blanche, P., Nissen, A. B., Torp-Pedersen, C., Gislason, G. H., Nelveg-Kristensen, K. E., Hommel, K., & Carlson, N. (2022). Acute kidney injury and risk of cardiovascular outcomes: A nationwide cohort study. Nefrologia, 42(3), 338-346. https://doi.org/10.1016/j.nefro.2021.06.007

Vancouver

Schytz PA, Blanche P, Nissen AB, Torp-Pedersen C, Gislason GH, Nelveg-Kristensen KE et al. Acute kidney injury and risk of cardiovascular outcomes: A nationwide cohort study. Nefrologia. 2022;42(3):338-346. https://doi.org/10.1016/j.nefro.2021.06.007

Author

Schytz, Philip Andreas ; Blanche, Paul ; Nissen, Anders Bonde ; Torp-Pedersen, Christian ; Gislason, Gunnar H ; Nelveg-Kristensen, Karl Emil ; Hommel, Kristine ; Carlson, Nicholas. / Acute kidney injury and risk of cardiovascular outcomes : A nationwide cohort study. In: Nefrologia. 2022 ; Vol. 42, No. 3. pp. 338-346.

Bibtex

@article{54f6afa4f01146f4a9f76d638d612aea,
title = "Acute kidney injury and risk of cardiovascular outcomes: A nationwide cohort study",
abstract = "BACKGROUND: Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, we investigated the hypothesis of increased one-year risk of cardiovascular event or death associated with AKI.METHODS: In a cohort study, we identified all admissions in Denmark between 2008 and 2018. AKI was defined as ≥1.5 times increase from baseline to peak creatinine during admission, or dialysis. We excluded patients with age <50 years, estimated glomerular filtration rate (eGFR) <15ml/min/1.73m 2, renal transplantation, index-admission due to cardiovascular disease or death during index-admission. The primary outcome was cardiovascular risk within one year from discharge, which was a composite of the secondary outcomes ischemic heart disease, heart failure or stroke. To estimate risks, we applied multiple logistic regression fitted by inverse probability of censoring weighting and stratified estimations by eGFR and age. We adjusted for proteinuria in the subcohort with measurements available. RESULTS: Among 565,056 hospital admissions, 39,569 (7.0%) cases of AKI were present. In total, 18,642 patients sustained a cardiovascular outcome. AKI was significantly associated with cardiovascular outcome with an adjusted OR [CI] of 1.33 [1.16-1.53], 1.43 [1.33-1.54], 1.23 [1.14-1.34], 1.38 [1.18-1.62] for eGFR ≥90, 60-89, 30-59 and 15-29ml/min/1.73m 2, respectively. When omitting the outcome heart failure, these results were 1.24 [1.06-1.45], 1.22 [1.11-1.33], 1.05 [0.95-1.16], 1.25 [1.02-1.54]. Results did not change substantially in strata of age groups, in AKI stages and in the subcohort adjusted for proteinuria. CONCLUSION: Non-selected patients aged 50 years or above with AKI during admission had significantly higher one-year risk of cardiovascular event or death, especially, but not only due to heart failure, independent of age and eGFR.",
author = "Schytz, {Philip Andreas} and Paul Blanche and Nissen, {Anders Bonde} and Christian Torp-Pedersen and Gislason, {Gunnar H} and Nelveg-Kristensen, {Karl Emil} and Kristine Hommel and Nicholas Carlson",
note = "Copyright {\textcopyright} 2021. Published by Elsevier Espa{\~n}a, S.L.U.",
year = "2022",
doi = "10.1016/j.nefro.2021.06.007",
language = "English",
volume = "42",
pages = "338--346",
journal = "Nefrologia",
issn = "0211-6995",
publisher = "Grupo Aula Medica S.A.",
number = "3",

}

RIS

TY - JOUR

T1 - Acute kidney injury and risk of cardiovascular outcomes

T2 - A nationwide cohort study

AU - Schytz, Philip Andreas

AU - Blanche, Paul

AU - Nissen, Anders Bonde

AU - Torp-Pedersen, Christian

AU - Gislason, Gunnar H

AU - Nelveg-Kristensen, Karl Emil

AU - Hommel, Kristine

AU - Carlson, Nicholas

N1 - Copyright © 2021. Published by Elsevier España, S.L.U.

PY - 2022

Y1 - 2022

N2 - BACKGROUND: Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, we investigated the hypothesis of increased one-year risk of cardiovascular event or death associated with AKI.METHODS: In a cohort study, we identified all admissions in Denmark between 2008 and 2018. AKI was defined as ≥1.5 times increase from baseline to peak creatinine during admission, or dialysis. We excluded patients with age <50 years, estimated glomerular filtration rate (eGFR) <15ml/min/1.73m 2, renal transplantation, index-admission due to cardiovascular disease or death during index-admission. The primary outcome was cardiovascular risk within one year from discharge, which was a composite of the secondary outcomes ischemic heart disease, heart failure or stroke. To estimate risks, we applied multiple logistic regression fitted by inverse probability of censoring weighting and stratified estimations by eGFR and age. We adjusted for proteinuria in the subcohort with measurements available. RESULTS: Among 565,056 hospital admissions, 39,569 (7.0%) cases of AKI were present. In total, 18,642 patients sustained a cardiovascular outcome. AKI was significantly associated with cardiovascular outcome with an adjusted OR [CI] of 1.33 [1.16-1.53], 1.43 [1.33-1.54], 1.23 [1.14-1.34], 1.38 [1.18-1.62] for eGFR ≥90, 60-89, 30-59 and 15-29ml/min/1.73m 2, respectively. When omitting the outcome heart failure, these results were 1.24 [1.06-1.45], 1.22 [1.11-1.33], 1.05 [0.95-1.16], 1.25 [1.02-1.54]. Results did not change substantially in strata of age groups, in AKI stages and in the subcohort adjusted for proteinuria. CONCLUSION: Non-selected patients aged 50 years or above with AKI during admission had significantly higher one-year risk of cardiovascular event or death, especially, but not only due to heart failure, independent of age and eGFR.

AB - BACKGROUND: Acute kidney injury (AKI) has been associated with cardiovascular disease, but this is sparsely studied in non-selected populations and with little attention to the effect in age and renal function. Using nationwide administrative data, we investigated the hypothesis of increased one-year risk of cardiovascular event or death associated with AKI.METHODS: In a cohort study, we identified all admissions in Denmark between 2008 and 2018. AKI was defined as ≥1.5 times increase from baseline to peak creatinine during admission, or dialysis. We excluded patients with age <50 years, estimated glomerular filtration rate (eGFR) <15ml/min/1.73m 2, renal transplantation, index-admission due to cardiovascular disease or death during index-admission. The primary outcome was cardiovascular risk within one year from discharge, which was a composite of the secondary outcomes ischemic heart disease, heart failure or stroke. To estimate risks, we applied multiple logistic regression fitted by inverse probability of censoring weighting and stratified estimations by eGFR and age. We adjusted for proteinuria in the subcohort with measurements available. RESULTS: Among 565,056 hospital admissions, 39,569 (7.0%) cases of AKI were present. In total, 18,642 patients sustained a cardiovascular outcome. AKI was significantly associated with cardiovascular outcome with an adjusted OR [CI] of 1.33 [1.16-1.53], 1.43 [1.33-1.54], 1.23 [1.14-1.34], 1.38 [1.18-1.62] for eGFR ≥90, 60-89, 30-59 and 15-29ml/min/1.73m 2, respectively. When omitting the outcome heart failure, these results were 1.24 [1.06-1.45], 1.22 [1.11-1.33], 1.05 [0.95-1.16], 1.25 [1.02-1.54]. Results did not change substantially in strata of age groups, in AKI stages and in the subcohort adjusted for proteinuria. CONCLUSION: Non-selected patients aged 50 years or above with AKI during admission had significantly higher one-year risk of cardiovascular event or death, especially, but not only due to heart failure, independent of age and eGFR.

U2 - 10.1016/j.nefro.2021.06.007

DO - 10.1016/j.nefro.2021.06.007

M3 - Journal article

C2 - 34489123

VL - 42

SP - 338

EP - 346

JO - Nefrologia

JF - Nefrologia

SN - 0211-6995

IS - 3

ER -

ID: 302166917